产品目录
| 编号 | 化学名称 | Cas号 | 纯度 | 化学结构 |
|---|---|---|---|---|
| 186213 | 艾菲康唑 | 164650-44-6 | >98% |  |
| 艾菲康唑是一种三唑类抗真菌药。它被批准用于加拿大和美国作为 | ||||
| 186157 | Erteberel | 533884-09-2 | >98% |  |
| Erteberel,也称为LY500307,选择性雌激素受体β受体激动剂(ERβ)是治疗良 | ||||
| 18671 | Edonerpic maleate | 519187-97-4 | >98% |  |
| Edonerpic，也被称为T-817，是一种神经保护剂。 | ||||
| 184124 | 内昔芬 E-异构体盐酸盐 | 1197194-61-8 | >98% |  |
| 内昔芬 E-异构体是一种他莫昔芬的代谢物和有效的选择性雌激素反 | ||||
| 184321 | Ensartinib ( X396 ) | 1370651-20-9 | >98% | _1370651-20-9.png) |
| Ensartinib is an orally available small molecule inhibitor of the receptor tyrosine k | ||||
| 18382 | eCF506 ( 别名：NXP 900 ) | 1914078-41-3 | ≧98.0% |  |
| eCF506靶向一种叫做Src酪氨酸激酶的分子，这是乳腺癌细胞生长和传 | ||||
| 1710121 | Esaxerenone | 1632006-28-0 | >98% |  |
| Esaxerenone（cs-3150，xl-550）是一种非甾体类抗盐皮质激素Exelixis发现 | ||||
| 179831 | EBE-A22 | 229476-53-3 | 98.0% |  |
| EBE-A22是PD 153035衍生物。EBE-A22，在EGF-R TK上无影响但保持高细胞毒 | ||||
| 011309 | EPZ015666 | 1616391-65-1 | 98% |  |
| EPZ-015666 是一种强效、选择性的口服生物药，PRMT5抑制剂与Ki为5 nm | ||||
| 178311 | EED226 | 2083627-02-3 | 98.0% |  |
| EED226是一种强效、选择性抑制剂，口服生物EED抑制剂。在EZH2MUT临 | ||||
| 651701 | 厄达替尼(JNJ-42756493) | 1346242-81-6 | 98% Min. | -cas-1346242-81-6.png) |
| Erdafitinib(JNJ-42756493) is a potent and selective panfibroblast growth factor recep | ||||
| 178157 | Ethyl 2-cyclohexyl-2-oxoacetate | 13275-31-5 | 96.0% |  |
| Ethyl 2-cyclohexyl-2-oxoacetate | ||||
| 178903 | E7449 | 1140964-99-3 | 98.0% |  |
| E7449是一种可口服的小分子抑制剂，核酶聚(ADP-核糖)聚合酶(PARP)1和 | ||||
| 2017878 | Elenbecestat ( E2609 ) | 1388651-30-6 | ≧98.0% | _1388651-30-6.png) |
| Elenbecestat是一种β-Site淀粉样前体蛋白裂解酶BACE）抑制剂，主要用 | ||||
| 20178213 | 依托泊苷磷酸酯 | 117091-64-2 | 98.0% |  |
| 依托泊苷磷酸盐是一种半合成足叶草毒素的磷酸盐。 | ||||
| 20178210 | Elamipretide | 736992-21-5 | 98% |  |
| Elamipretide, 也称为MTP-131或D-Arg-Dmt-Lys-Phe-NH2，是一种心肌过氧化酶抑 | ||||
| 20177314 | [(1S)-2-(3,5-二氟苯基)-1-[(2S)-环氧乙烷基]乙基]氨基甲酸叔丁酯 | 388071-27-0 | 98.0% |  |
| [(1S)-2-(3,5-二氟苯基)-1-[(2S)-环氧乙烷基]乙基]氨基甲酸叔丁酯 | ||||
| 17031018 | Etrasimod | 1206123-37-6 | 99.73% |  |
| Etrasimod，也被称为APD334，是一种多功能S1P1受体的功能拮抗剂，用 | ||||
| 17031010 | eFT-508 | 1849590-01-7 | 98% | |
| eFT-508 (eFT508)是一种有效且选择性的MNK1 / 2抑制剂，可能导致肿瘤细 | ||||
| 17022806 | 盐酸Epetraborole | 1234563-16-6 | 98% | |
| 盐酸Epetraborole是一种新型的leucyl - trna合成酶(LeuRS)抑制剂。 | ||||
| 17022718 | 依利格鲁司特 | 491833-29-5 | 98% |  |
| 依利格鲁司特, 也叫Genz-112638, 是一种有效的选择性的葡萄糖酰胺合 | ||||
| 17011802 | EX-527 S-enantiomer | 848193-68-0 | 98% |  |
| EX-527 S-enantiomer是一种有效的选择性SIRT1抑制剂，IC50为123 nM;没有对 | ||||
| 17011801 | EX-527 R-enantiomer | 848193-69-1 | 98% |  |
| EX-527 R-enantiomer是对活性形式EX-527 S-enantiomer(推测为参考)的负控制 | ||||
| 17011301 | 4E1RCat | 328998-25-0 | 98% |  |
| 4E1RCat是eIF4F翻译起始复合物的一种抑制剂，它阻止eIF4E:eIF4G和eIF4E | ||||
| 17011103 | Etomoxir钠盐 | 828934-41-4 | 98% | |
| Etomoxir是一种在线粒体内膜的外表面的一种不可逆转的CPT-1抑制剂 | ||||
| 711401 | Eganelisib ( IPI-549 ) | 1693758-51-8 | ≧98.0% |  |
| Eganelisib (IPI-549) 是一种首创、口服、高选择性 PI3Kγ 抑制剂，单独 | ||||
| 16122944 | Ezutromid | 945531-77-1 | 98% |  |
| Ezutromid, also known as BMN-195 and SMTC-1100, is a first orally bioavailable utroph | ||||
| 16122943 | EXP-3174 | 124750-92-1 | 98% |  |
| EXP-3174, also known as Losartan Carboxylic Acid, is a physiologically active metabol | ||||
| 16122942 | Ertiprotafib | 251303-04-5 | 98% |  |
| Ertiprotafib, also known as PTP-112, is a Protein Tyrosine Phosphatase 1B Inhibitor ( | ||||
| 16122941 | Eptapirone | 179756-85-5 | 98% | |
| Eptapirone, also known as F11440, is a potent, selective, high efficacy 5-HT1A recept | ||||